Penetrancia xenética (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Penetrancia xenética" in Galician language version.

refsWebsite

Global rank Galician rank

4^th place

6^th place

2^nd place

7^th place

5^th place

11^th place

doi.org

Bessett JH; et al. (Feb 1998). "Characterization of mutations in patients with multiple endocrine neoplasia type 1". American Journal of Human Genetics 62 (2): 232–44. PMC 1376903. PMID 9463336. doi:10.1086/301729.
Hughes, David J. (2008-02-19). "Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers". Familial Cancer (Springer Netherlands) 7 (3): 233–244. ISSN 1573-7292. PMID 18283561. doi:10.1007/s10689-008-9181-0.
Beutler, Ernest (2003-05-01). "Penetrance in hereditary hemochromatosis: The HFE Cys282Tyr mutation as a necessary but not sufﬁcient cause of clinical hereditary hemochromatosis". Blood 101 (9): 3347–3350. PMID 12707220. doi:10.1182/blood-2002-06-1747.
KJ Allen, LC Gurrin, CC Constantine; et al. (2008-01-17). "Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis". New England Journal of Medicine 358 (3): 221–230. PMID 18199861. doi:10.1056/NEJMoa073286.

Bessett JH; et al. (Feb 1998). "Characterization of mutations in patients with multiple endocrine neoplasia type 1". American Journal of Human Genetics 62 (2): 232–44. PMC 1376903. PMID 9463336. doi:10.1086/301729.
Hughes, David J. (2008-02-19). "Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers". Familial Cancer (Springer Netherlands) 7 (3): 233–244. ISSN 1573-7292. PMID 18283561. doi:10.1007/s10689-008-9181-0.
Beutler, Ernest (2003-05-01). "Penetrance in hereditary hemochromatosis: The HFE Cys282Tyr mutation as a necessary but not sufﬁcient cause of clinical hereditary hemochromatosis". Blood 101 (9): 3347–3350. PMID 12707220. doi:10.1182/blood-2002-06-1747.
KJ Allen, LC Gurrin, CC Constantine; et al. (2008-01-17). "Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis". New England Journal of Medicine 358 (3): 221–230. PMID 18199861. doi:10.1056/NEJMoa073286.

Hughes, David J. (2008-02-19). "Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers". Familial Cancer (Springer Netherlands) 7 (3): 233–244. ISSN 1573-7292. PMID 18283561. doi:10.1007/s10689-008-9181-0.